<?xml version="1.0" encoding="UTF-8"?>
<document id="29512714">
	<sentence id="s1" text="The tumor suppressor characteristics of cyclin-dependent kinase 10 (peptidyl-threonine phosphorylation) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.">
		<entity id="s1.e1" charOffset="4-9"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="68-102"
			type="GO" text="peptidyl-threonine phosphorylation" ontology_id="GO_0018107"/>
		<entity id="s1.e3" charOffset="143-149"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="In the present study the expression status of peptidyl-threonine phosphorylation and its prognostic significance in gastric cancer was determined, as well as its role in cell proliferation and invasion.">
		<entity id="s2.e1" charOffset="46-80"
			type="GO" text="peptidyl-threonine phosphorylation" ontology_id="GO_0018107"/>
		<entity id="s2.e2" charOffset="124-130"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Immunoblot analysis revealed that peptidyl-threonine phosphorylation protein expression was notably decreased in gastric cancer compared with normal tissues.">
		<entity id="s3.e1" charOffset="34-68"
			type="GO" text="peptidyl-threonine phosphorylation" ontology_id="GO_0018107"/>
		<entity id="s3.e2" charOffset="121-127"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Immunohistochemistry demonstrated that the loss of peptidyl-threonine phosphorylation expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (PAAAA0.001), frequent lymph node metastasis (PAAAA0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (PAAAA0.001).">
		<entity id="s4.e1" charOffset="51-85"
			type="GO" text="peptidyl-threonine phosphorylation" ontology_id="GO_0018107"/>
		<entity id="s4.e2" charOffset="145-151"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s4.e3" charOffset="208-213"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
	<sentence id="s5" text="Multivariate analysis suggested that peptidyl-threonine phosphorylation expression may serve as an independent prognostic predictor (P=0.001) for the progression of gastric cancer.">
		<entity id="s5.e1" charOffset="37-71"
			type="GO" text="peptidyl-threonine phosphorylation" ontology_id="GO_0018107"/>
		<entity id="s5.e2" charOffset="173-179"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
	<sentence id="s6" text="In addition, ectopic peptidyl-threonine phosphorylation expression inhibited gastric cancer cell proliferation, migration and invasion, while knockdown of CDK10 promoted these phenotypes.">
		<entity id="s6.e1" charOffset="21-55"
			type="GO" text="peptidyl-threonine phosphorylation" ontology_id="GO_0018107"/>
		<entity id="s6.e2" charOffset="85-91"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s6.p1" e1="s6.e1"
		    e2="s6.e2" pgr="false"/>
	</sentence>
</document>
